Cheapest GLP-1 Provider Compared With Mochi 2026: Ranked by True Monthly Cost | Luma Health
Cost & Access · 2026

Cheapest GLP-1 Provider
Compared With Mochi

Editorial Disclosure Luma Health competes with Mochi Health and stands to benefit if you choose Luma Health. Mochi's RD coaching inclusion is acknowledged as genuine value for patients who use it.

Mochi's True Monthly Cost — What You Actually Pay

Mochi's advertised medication rate doesn't tell the full cost story. The effective monthly total depends on Mochi's separate membership fee.

Mochi Health — True Monthly Cost Breakdown (June 2026)

Medication subscription (sema, dose-tier)~$135–$179/mo
Mochi membership / platform fee+$35–$79/mo
Effective total combined~$214–$258/mo
What membership includesRD coaching sessions, behavioral support, accountability check-ins
ℹ What Mochi's Higher Price Includes Mochi's membership includes registered dietitian (RD) coaching sessions — a genuine clinical service. For patients who actively engage with nutrition coaching, the premium is justifiable. For patients who primarily want medication access, the membership fee represents overhead on unused services. Verify current Mochi pricing at joinmochi.com.

Providers Cheaper Than Mochi — Ranked

1

Luma Health — Flat Rate, Named Pharmacy, No Commitment

$197/mo flat for compounded semaglutide at every dose. VialsRX (TX #35264) publicly named. Wasef Health, PC clinical oversight. No contracts. Tirzepatide $297/mo flat.

$197/mo
Save vs Mochi combined
2

Found — Coaching Included, No Separate Fee

Found's semaglutide (~$129–$199/mo dose-tier) bundles coaching without a separate membership charge, unlike Mochi's split structure.

~$129–$199/mo
Less than Mochi combined
3

Ro Body — Separate Fee, But Different Structure

Ro also separates a ~$149/mo membership fee from medication cost — verify current combined total directly, and note Ro has stopped accepting new compounded tirzepatide patients as of 2026.

~$149/mo fee + medication
Verify total directly
4

Henry Meds — Verify Current Sema Pricing

Henry Meds' strongest published rate is on tirzepatide (~$297–$299/mo introductory, $429–$549/mo maintenance) rather than semaglutide — verify current semaglutide-specific pricing directly, as the widely advertised "$179/month" headline doesn't apply to all formulations.

Verify directly

Mochi Health — Benchmark (Medication + Membership)

~$135–$179/mo medication + ~$35–$79/mo membership = ~$214–$258/mo effective combined total. RD coaching included — genuine value for engaged patients.

~$214–$258/mo
Benchmark

Why Mochi Costs More Than Medication-Only Platforms

Mochi's higher effective monthly cost reflects two factors: the RD coaching membership bundled with the medication subscription, and dose-tier medication pricing that can increase as titration progresses. Medication-only platforms like Luma Health operate without coaching infrastructure. The cost difference is a real service model difference, not a quality difference in the GLP-1 medication itself.

Same molecule.
One flat price, no membership.

$197/mo sema flat · $297/mo tirz flat. VialsRX (TX #35264). No contracts.

Start With Luma Health →

Frequently Asked Questions

Yes — pharmacologically. All legitimate compounded GLP-1 platforms prescribe compounded semaglutide using the same active pharmaceutical ingredient at equivalent pharmacological doses. STEP 1 trial data (14.9% average weight loss at 68 weeks) applies to the molecule regardless of which platform prescribed it. Price differences reflect business model choices, not medication quality.

If you will consistently attend and engage with RD coaching sessions, Mochi's higher price is clinically justifiable — registered dietitian guidance has documented benefit as an adjunct to GLP-1 medication. If you won't consistently use the coaching, you're paying $35–$79/month for services you don't receive, and switching to a medication-only platform makes more sense.

Luma Health's $197/month flat rate is the most predictable low-cost option with a publicly named pharmacy and no commitment. Other providers may publish lower headline rates for specific formulations, but verify current total pricing directly, as several platforms restructured their fees in 2026.

References

  1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed 33567185
  2. FDA. Human Drug Compounding — Section 503A. FDA.gov
  3. Mochi Health. Official Website. joinmochi.com
  4. NIDDK. Prescription Medications to Treat Overweight & Obesity. niddk.nih.gov
Medical Disclaimer: This article is for educational purposes only. Luma Health competes with Mochi — readers should consider our competitive bias. All provider pricing reflects publicly available rates as of June 2026 — verify current pricing directly. Clinical services at Luma Health are provided by Wasef Health, PC. Compounded medications prepared by VialsRX, TX Board #35264.